Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

about

Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.

P2860

Q38092131-A4435B2B-9962-402A-BFD9-FDA6061B1217 Q38660708-6751A866-DFDA-4953-8ACF-F771B0A150AC

P2860

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

Item

http://www.wikidata.org/entity/Q38043013

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

@en

type

Item

label

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

@en

prefLabel

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

@en

P1476

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

@en

P2093

Baoying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration

Complement factor H polymorphism in age-related macular degeneration

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

A look at autoimmunity and inflammation in the eye

Emerging drugs for uveitis

The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples

Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity

Complement factor H variant increases the risk of age-related macular degeneration

HTRA1 promoter polymorphism in wet age-related macular degeneration

P304

315-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09273948.2012.710706

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert B Nussenblatt

H. Nida Sen

P577

2012-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22974049

http://www.w3.org/2001/XMLSchema#string

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

about

P2860

P2860

Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698